市場調査レポート

商品コード

1633568

感覚異常治療の市場規模、シェア、成長分析：疾患タイプ別、適応症別、薬剤クラス別、流通チャネル別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Paresthesia Treatment Market Size, Share, Growth Analysis, By Disorder Type (Acute Paresthesia, Chronic Paresthesia), By Indication (Radiculopathy, Neuropathy), By Drug Class, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月11日
発行: SkyQuest
ページ情報: 英文 203 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 514,465円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 646,756円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 779,047円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

感覚異常治療の世界市場規模は2023年に55億米ドルと評価され、2024年の57億1,000万米ドルから2032年には76億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは3.8％で成長する見通しです。

身体の様々な部位（特に手や足）の灼熱感、ピリピリ感、しびれなどの感覚を特徴とする感覚異常は、様々な医学的問題の重要な指標として認識されつつあります。神経の損傷、圧迫、血流障害に根ざしたこの症状は、1型および2型糖尿病、ビタミン欠乏症、神経障害、手根管症候群などの根本的な問題を知らせることが多いです。これらの相関性に対する認識が高まるにつれ、治療ソリューションに対する需要の高まりとともに、知覚異常の原因をターゲットとした診断薬や治療薬に対する潜在的な市場機会が存在します。ヘルスケアプロバイダーや製薬会社は、この複雑な症状に効果的に対処するための標的治療薬や患者教育リソースを開発することで、この市場に資本投下することができ、このような苦痛を伴う症状を経験する患者の管理オプションを強化することができます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Medtronic plc（Ireland）
Boston Scientific Corporation（United States）
Abbott Laboratories（United States）
Nevro Corp.（United States）
Stryker Corporation（United States）
Pfizer Inc.（United States）
GlaxoSmithKline plc（United Kingdom）
Baxter International Inc.（United States）
Glenmark Pharmaceuticals Ltd.（India）
Omron Healthcare, Inc.（United States）
Stimwave LLC（United States）
Cyberonics, Inc.（United States）
EnteroMedics Inc.（United States）
Bio-Medical Research Ltd.（United Kingdom）
Sanofi S.A.（France）
Bristol-Myers Squibb Company（United States）
Johnson & Johnson（United States）
Novartis International AG（Switzerland）
AstraZeneca plc（United Kingdom）

結論と推奨事項

Product Code: SQMIG35A2802

Global Paresthesia Treatment Market size was valued at USD 5.5 billion in 2023 and is poised to grow from USD 5.71 billion in 2024 to USD 7.69 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

Paresthesia, characterized by sensations like burning, tingling, and numbness in various body parts (especially hands and feet), is increasingly recognized as a significant indicator of various medical issues. Rooted in nerve damage, compression, or impaired blood flow, this condition often signals underlying problems, including type 1 and type 2 diabetes, vitamin deficiencies, neurological disorders, and carpal tunnel syndrome. As awareness of these correlations grows, there is a potential market opportunity for diagnostics and treatments targeting the causes of paresthesia, alongside increased demand for therapeutic solutions. Healthcare providers and pharmaceutical companies could capitalize on this market by developing targeted therapies and patient education resources to address this complex condition effectively, enhancing management options for patients experiencing these distressing symptoms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paresthesia Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Paresthesia Treatment Market Segmental Analysis

Global Paresthesia Treatment Market is segmented by Disorder Type, Indication, Drug Class, Distribution Channel, End User and region. Based on Disorder Type, the market is segmented into Acute Paresthesia and Chronic Paresthesia. Based on Indication, the market is segmented into Radiculopathy and Neuropathy. Based on Drug Class, the market is segmented into Anticonvulsants, Immunosuppressants, Antidepressants, Opioids and Other. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on End User, the market is segmented into Hospitals, Clinics and Diagnosis Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Paresthesia Treatment Market

The global market for paresthesia treatment is significantly driven by the rising prevalence of chronic illnesses, including diabetes, neuropathy, and autoimmune disorders. These medical conditions often lead to paresthesia, which is marked by abnormal sensations like tingling and numbness. As paresthesia frequently indicates underlying health issues, the demand for effective management and treatment options is escalating. Furthermore, with more individuals undergoing anesthesia procedures, healthcare professionals must cater to the growing population of patients experiencing anesthesia-related complications, further amplifying the need for innovative and accessible solutions in the paresthesia treatment market.

Restraints in the Global Paresthesia Treatment Market

Restraints in the Global Paresthesia Treatment market include the potential adverse effects linked to specific therapies. Patients undergoing treatments like nerve stimulation or chemotherapy may encounter reactions such as discomfort or complications, which could hinder their acceptance of these methods. Concerns regarding safety and tolerability significantly impact both patient and physician willingness to adopt these interventions. Furthermore, the variability in individual responses to treatments poses a unique challenge for healthcare professionals, who must thoughtfully consider and customize treatment plans for each patient to ensure optimal outcomes, emphasizing the importance of a mindful and personalized approach in managing paresthesia.

Market Trends of the Global Paresthesia Treatment Market

The Global Paresthesia Treatment market is witnessing a significant upward trend, primarily fueled by the rising prevalence of neurological disorders like multiple sclerosis, diabetic neuropathy, and carpal tunnel syndrome. As the global population ages, the susceptibility to conditions such as strokes and other neurological diseases is increasing, intensifying the demand for effective anesthetic treatments. Furthermore, technological advancements in therapeutic devices, including transcutaneous electrical stimulation (TENS) and ultrasound devices, are enhancing treatment efficacy and patient outcomes. This convergence of demographic shifts and innovation in treatment modalities is expected to propel substantial growth in the paresthesia treatment market throughout the forecast period.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Paresthesia Treatment Market Size by Disorder Type & CAGR (2025-2032)

Market Overview
Acute Paresthesia
Chronic Paresthesia

Global Paresthesia Treatment Market Size by Indication & CAGR (2025-2032)

Market Overview
Radiculopathy
Neuropathy

Global Paresthesia Treatment Market Size by Drug Class & CAGR (2025-2032)

Market Overview
Anticonvulsants
Immunosuppressants
Antidepressants
Opioids
Other

Global Paresthesia Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Paresthesia Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Diagnosis Centers

Global Paresthesia Treatment Market Size & CAGR (2025-2032)

North America (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- US
- Canada
Europe (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glenmark Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EnteroMedics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Medical Research Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

感覚異常治療の市場規模、シェア、成長分析：疾患タイプ別、適応症別、薬剤クラス別、流通チャネル別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Paresthesia Treatment Market Size, Share, Growth Analysis, By Disorder Type (Acute Paresthesia, Chronic Paresthesia), By Indication (Radiculopathy, Neuropathy), By Drug Class, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

感覚異常治療市場規模：疾患タイプ別& CAGR（2025-2032）

感覚異常治療市場規模：適応症別& CAGR（2025-2032）

感覚異常治療市場規模：薬剤クラス別& CAGR（2025-2032）

感覚異常治療市場規模：流通チャネル別& CAGR（2025-2032）

感覚異常治療市場規模：エンドユーザー別& CAGR（2025-2032）

感覚異常治療市場規模：地域別& CAGR（2025-2032）